Patient Leaflet Updated 21-Nov-2022 | Novo Nordisk Limited
Fiasp 100 units/mL solution for injection in vial
Fiasp®
100 units/mL solution for injection in vial
insulin aspart
1 What Fiasp® is and what it is used for
2 What you need to know before you use Fiasp®
3 How to use Fiasp®
4 Possible side effects
5 How to store Fiasp®
6 Contents of the pack and other information
Fiasp® is a mealtime insulin with a fast-acting blood sugar lowering effect. Fiasp® is a solution for injection containing insulin aspart and is used to treat diabetes mellitus in adults, adolescents and children aged 1 year and above. Diabetes is a disease where your body does not produce enough insulin to control the level of blood sugar. Treatment with Fiasp® helps to prevent complications from your diabetes.
Fiasp® should be injected up to 2 minutes before the start of the meal, with an option to inject up to 20 minutes after starting the meal.
This medicine has its maximum effect between 1 and 3 hours after the injection and the effect lasts for 3 to 5 hours.
This medicine should normally be used in combination with intermediate-acting or long-acting insulin preparations.
This medicine can also be used for continuous infusion in a pump system.
Talk to your doctor, pharmacist or nurse before using Fiasp®. Be especially aware of the following:
Some conditions and activities can affect how much insulin you need. Talk to your doctor:
When using Fiasp® it is strongly recommended that the name and batch number of each package is recorded in order to maintain a record of the batches used.
Skin changes at the injection site
The injection site should be rotated to help prevent changes to the fatty tissue under the skin, such as skin thickening, skin shrinking or lumps under the skin. The insulin may not work very well if you inject into a lumpy, shrunken or thickened area (see section 3 ‘How to use Fiasp®’). Tell your doctor if you notice any skin changes at the injection site. Tell your doctor if you are currently injecting into these affected areas before you start injecting in a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.
This medicine is not recommended for use in children below the age of 1 year.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Some medicines affect your blood sugar level - this may mean your insulin dose has to change.
Listed below are the most common medicines which may affect your insulin treatment.
Your blood sugar level may fall (hypoglycaemia) if you take:
Your blood sugar level may rise (hyperglycaemia) if you take:
Octreotide and lanreotide - used to treat a rare condition involving too much growth hormone (acromegaly). They may increase or decrease your blood sugar level.
If any of the above applies to you (or you are not sure), talk to your doctor or pharmacist.
If you drink alcohol, your need for insulin may change as your blood sugar level may either rise or fall. You should therefore monitor your blood sugar level more often than usual.
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. This medicine can be used during pregnancy; however your insulin dose may need to be changed during pregnancy and after delivery. The amount of insulin you need usually falls during the first 3 months of pregnancy and increases for the remaining 6 months. Careful control of your diabetes is needed in pregnancy. Avoiding low blood sugar (hypoglycaemia) is particularly important for the health of your baby. After you have had your baby your insulin requirements will likely return to how much you needed before your pregnancy.
There are no restrictions on treatment with Fiasp® during breast–feeding.
Having low blood sugar can affect your ability to drive or use any tools or machines. If your blood sugar is low, your ability to concentrate or react might be affected. This could be dangerous to yourself or others. Ask your doctor whether you can drive if:
This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’.
Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Fiasp® is a mealtime insulin.
Adults: Fiasp® should be injected right before (0-2 minutes) the start of the meal, with an option to inject up to 20 minutes after starting the meal.
Children: Fiasp® should be injected right before (0-2 minutes) the start of the meal, with the possibility to inject up to 20 minutes after starting the meal in situations, when there is uncertainty about how the child will eat. Ask your doctor for advice on these situations.
This medicine has its maximum effect between 1 and 3 hours after the injection and the effect lasts for 3 to 5 hours.
Dose for type 1 and type 2 diabetes
Your doctor will decide together with you:
If you want to change your usual diet, check with your doctor, pharmacist or nurse first as a change in diet may alter your need for insulin.
When using other medicines, ask your doctor if your treatment needs to be adjusted.
Dose adjustment for type 2 diabetes
The daily dose should be based on your blood sugar level at mealtimes and bedtime from the previous day.
Dose adjustment for mealtime or bedtime blood sugar:
Reduce dose by one unit if less than 4mmol/L or less than 71 mg/dL
No dose adjustment for 4-6 mmol/L or 71-108 mg/dL
Increase dose by 1 unit if more than 6mmol/L or more than 108mg/dL
Use in elderly patients (65 years or older)
This medicine can be used in elderly patients. Talk to your doctor about changes in your dose.
If you have kidney or liver problems
If you have kidney or liver problems you may need to check your blood sugar level more often. Talk to your doctor about changes in your dose.
This medicine is for injection under the skin (subcutaneous injection) or for continuous infusion in pumps. Administration in a pump will require a comprehensive instruction by your healthcare professional.
Before you use Fiasp® for the first time, your doctor or nurse will show you how to use it.
1 Check the name and strength on the label of the vial to make sure it is Fiasp®.
2 Remove the protective cap from the vial.
3 Always use a new needle and syringe for each injection to prevent contamination. Needles and syringes must not be shared.
4 Draw into the syringe the same amount of air as the dose of insulin you are going to inject. Inject the air into the vial.
5 Turn the vial and syringe upside down and draw the correct insulin dose into the syringe. Pull the needle out of the vial. Push the air out of the syringe and check that the dose is correct.
6 Inject the insulin under the skin. Use the injection technique advised by your doctor or nurse.
7 Throw away the needle after each injection.
Follow the instructions and recommendations from your doctor regarding the use of Fiasp® in a pump. Before using Fiasp® in the pump system, you must have received a comprehensive instruction in the use and information about any actions to be taken in case of illness, high or low blood sugar or failure of the pump system. If you use Fiasp® from a vial in an infusion pump system it can be used for a maximum of 6 days.
To get the benefit of insulin infusion and to detect possible malfunction of the insulin pump, it is recommended that you measure your blood sugar level regularly.
You should always have an alternative delivery method for your insulin available for injection under the skin (for example, a pen injector or syringes) in case the pump system fails.
If you use too much insulin your blood sugar may get too low (hypoglycaemia), see advice in section 4 under ‘Low blood sugar’.
If you forget to use your insulin your blood sugar may get too high (hyperglycaemia). See section 4 under ‘High blood sugar’.
Do not stop using your insulin without talking to your doctor. If you stop using your insulin this could lead to a very high blood sugar level (severe hyperglycaemia) and ketoacidosis (a condition with too much acid in the blood which is potentially life-threatening). See symptoms and advice in section 4 under ‘High blood sugar’.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Low blood sugar (hypoglycaemia) is very common with insulin treatment (may affect more than 1 in 10 people). It can be very serious. If your blood sugar level falls too much you may become unconscious. Serious hypoglycaemia may cause brain damage and may be life-threatening. If you have symptoms of low blood sugar, take actions immediately to increase your blood sugar level. See advice in ‘Low blood sugar’ below.
If you have a serious allergic reaction (including an anaphylactic shock) to insulin or any of the ingredients in Fiasp® (how often this occurs is not known), stop using this medicine and contact emergency medical service straight away.
Signs of a serious allergic reaction may include:
Allergic reactions such as generalised skin rash and facial swelling may occur. These are uncommon and may affect up to 1 in 100 people. See a doctor if the symptoms worsen or you see no improvement in a few weeks.
Skin changes at the injection site: If you inject insulin at the same place, the fatty tissue may shrink (lipoatrophy) or thicken (lipohypertrophy) (these are uncommon and may affect up to 1 in 100 people). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis; how often this occurs is not known). The insulin may not work very well if you inject into a lumpy, shrunken or thickened area. Change the injection site with each injection to help prevent these skin changes.
Common (may affect up to 1 in 10 people)
Reaction at administration site: Local reactions at the place you inject yourself may occur. The signs may include: rash, redness, inflammation, bruising, irritation, pain and itching. The reactions usually disappear after a few days.
Skin reactions: Signs of allergy on the skin such as eczema, rash, itching, hives and dermatitis may occur.
General effects from insulin treatment including Fiasp®
Low blood sugar may happen if you:
Drink alcohol; use too much insulin; exercise more than usual; eat too little or miss a meal.
Headache; slurred speech; fast heartbeat; cold sweat; cool pale skin; feeling sick; feeling very hungry; tremor or feeling nervous or worried; feeling unusually tired, weak and sleepy; feeling confused; difficulty in concentrating; short-lasting changes in your sight.
Tell everyone you spend time with that you have diabetes. Tell them what could happen if your blood sugar gets too low, including the risk of passing out.
Let them know that if you pass out, they must:
You may recover more quickly from passing out with an injection of glucagon. This can only be given by someone who knows how to use it.
If severe low blood sugar is not treated over time, it can cause brain damage. This can be short or long-lasting. It may even cause death.
This is because the dosing or timing of your insulin injections, food or exercise may need to be changed.
High blood sugar may happen if you:
Eat more or exercise less than usual; drink alcohol; get an infection or a fever; have not used enough insulin; keep using less insulin than you need; forget to use your insulin or stop using insulin.
Flushed skin; dry skin; feeling sleepy or tired; dry mouth; fruity (acetone) breath; urinating more often; feeling thirsty; losing your appetite; feeling or being sick (nausea or vomiting).
These may be signs of a very serious condition called ketoacidosis. This is a build-up of acid in the blood because the body is breaking down fat instead of sugar. If not treated, this could lead to diabetic coma and eventually death.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via
Great Britain:
or search for MHRA Yellow Card in the Google Play or Apple App Store
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton, after ‘EXP’. The expiry date refers to the last day of that month.
Before first use
Store in a refrigerator (2°C-8°C). Do not freeze. Keep away from the freezing element. Keep the vial in the carton in order to protect from light.
After first opening or if carried as a spare
You can carry your vial with you and keep it at room temperature (not above 30°C) or in a refrigerator (2°C-8°C) for up to 4 weeks (including time in a pump reservoir). Always keep the vial in the carton in order to protect from light.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Fiasp® is presented as a clear, colourless and aqueous solution for injection in a vial. Each vial contains 10 mL solution.
Pack sizes of 1, 5 or a multipack with 5 x (1 x 10 mL) vials. Not all pack sizes may be marketed.
This leaflet was last revised in 08/2022
Fiasp® is a trademark owned by Novo Nordisk A/S, Denmark
© 2022
Novo Nordisk A/S
3 City Place, Beehive Ring Road, Gatwick, West Sussex, RH6 0PA
+44 (0)1293 613535
+44 (0)800 023 2573
http://www.novonordisk.co.uk
+44 (0)1293 613555
+44 (0)800 023 2573